Analyst Ratings for AstraZeneca (AZN)

AZN Rating Summary

AZN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AZN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $71.75 (+11.2%) * Over Last 12-Mos
Rating Score: 5.7 / 10   Percentile Rank: 57%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/11/2022 DZ Bank Elmar Kraus Upgrade Hold
(Sell)
N/A
(N/A)
58.60
(64.54)
10.14% Details
4/12/2021 Argus
» Updated 4/14/2021
John Eade Downgrade Hold
(Buy)
N/A
(N/A)
49.94
(64.54)
29.24% Details
Like AZN Ratings? Also take a look at HCM, PFE, ALXN, MRNA

AZN Ratings News